ボルヒアルロニダーゼアルファ (遺伝子組換え) (JAN);
ヒアルロニダーゼ (ヒト組換え型);
Hyaluronidase (human recombinant) (USAN);
Vorhyaluronidase alfa (genetical recombination) (JAN)

HYALURONIDASE (HF Acquisition Co LLC), HYLENEX RECOMBINANT (A-S Medication Solutions), HYLENEX RECOMBINANT (Antares Pharma)

C2327H3553N589O667S20

51060.6624

51092.9558

LNFRAPPVIP NVPFLWAWNA PSEFCLGKFD EPLDMSLFSF IGSPRINATG QGVTIFYVDR
LGYYPYIDSI TGVTVNGGIP QKISLQDHLD KAKKDITFYM PVDNLGMAVI DWEEWRPTWA
RNWKPKDVYK NRSIELVQQQ NVQLSLTEAT EKAKQEFEKA GKDFLVETIK LGKLLRPNHL
WGYYLFPDCY NHHYKKPGYN GSCFNVEIKR NDDLSWLWNE STALYPSIYL NTQQSPVAAT
LYVRNRVREA IRVSKIPDAK SPLPVFAYTR IVFTDQVLKF LSQDELVYTF GETVALGASG
IVIWGTLSIM RSMKSCLLLD NYMETILNPY IINVTLAAKM CSQVLCQEQG VCIRKNWNSS
DYLHLNPDNF AIQLEKGGKF TVRGKPTLED LEQFSEKFYC SCYSTLSCKE KADVKDTDAV
DVCIADGVCI DAFLKPPMET EEPQIFY
(Disulfide bridge: 25-316, 189-203, 341-352, 346-400, 402-408, 423-429; Glycosylation site: 47, 131, 200, 219, 333, 358, 440)

伝播補助剤

ヒアルロニダーゼ [KO:K01197] [EC:3.2.1.35]